Nocturnal blood pressure fall and metabolic syndrome score in hypertensive patients

Blood Pressure Monitoring

Volumn 12, Issue 6, 2007, Pages 351-356

  Vyssoulis, Gregory P ^a   Karpanou, Eva A ^b   Kyvelou, Stella Maria G ^a,c   Adamopoulos, Dionysios N ^a   Deligeorgis, Alexandros D ^a   Spanos, Panagiotis G ^a   Pietri, Panagiota G ^a   Cokkinos, Dennis F ^b   Stefanadis, Christodoulos I ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

^c NONE   (Greece)

Author keywords

Ambulatory blood pressure monitoring; Dipping status; Hypertension; Metabolic syndrome score

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE FLUCTUATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NOCTURNAL BLOOD PRESSURE FALL; OUTPATIENT DEPARTMENT; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SLEEP;

EID: 40349108424     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBP.0b013e3282cb5ad3     Document Type: Article

References (32)

1. Palatini P. Too much of a good thing? A critique of overemphasis of the use of ambulatory blood pressure monitoring in clinical practice. J Hypertens 2002; 20:1917-1923.
2. Parati G, Mancia G. Ambulatory blood pressure monitoring in clinical practice. J Hypertens 2002; 20:1925-1927.
3. Staessen J, Bieniaszweski L, O'Brien E, Gosse P, Hayashi H, Imai Y, et al. Nocturnal blood pressure fall on ambulatory monitoring in a large international database. Hypertension 1997; 29:30-39.
4. O'Brien E, Sheridan J, O'Malley K. Dippers and non dippers (letter). Lancet 1988; 2:397.
5. O'Brien E, Atkins A, Staessen J. Are overnight dip and target organ damage related? A clinical perspective. Blood Press Monit 1996; 1:41-46.
6. Lind L, Andersson PE, Andern B, Hanni A, Lithell HO. Left ventricular hypertrophy in hypertension is associated with insulin-resistance metabolic syndrome. J Hypertens 1995; 13:433-438.
7. Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminouria and the metabolic syndrome: NHANES III. Am J Hypertens 2003; 16:952-958.
8. Suzuki M, Shinozaki K, Kanazawa A, Hara Y, Hattori Y, Tsushima M, et al. Insulin resistance as an independent risk factor for carotid wall thickening. Hypertension 1996; 28:538-544.
9. Lakka M, Laaksonen E, Lakka A, Niskanen K, Kompusalo E, Tuomilehto J, et al. The metabolic syndrome and total cardiovascular disease mortality in middle-aged men. J Am Med Assoc 2002; 288:2709-2716.
10. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive subjects: advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27:130-135.
11. Tsementzis A, Gill S, Hitchcock R, Gill K, Beevers G. Diurnal variation of and activity during the onset of stroke. Neurosurgery 1985; 17: 901-904.
12. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007; 30:8-13.
13. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reily D, Haffner S, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108:414-419.
14. Ridker P, Buring J, Cook N, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003; 107:391-397.
15. Alexander C, Landsman P, Teutsch S, Haffner S. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants aged 50 years and older. Diabetes 2003; 52:1210-1214.
16. Rutter M, Parise H, Benjamin E, Levy D, Larson M, Meigs J, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 2003; 107:448-454.
17. European Society of Hypertension. European Society of Cardiology guidelines for the management of arterial hypertension. Guidelines Committee. J Hypertens 2003; 21:1011-1053.
18. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22:1991-1998.
19. Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 2004; 43:1817-1822.
20. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81:528-536.
21. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793-801.
22. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. J Am Med Assoc 1999; 282:539-546.
23. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994; 7:23-29.
24. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38:852-857.
25. Higashi Y, Nakagawa K, Kimura M, Noma K, Hara K, Sasaki S, et al. Circardian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and non-dippers. J Am Coll Cardiol 2002; 40:2039-2043.
26. Parati G. Blood pressure reduction at night: sleep and beyond. J Hypertens 2000; 18:1725-1729.
27. Sherwood A, Steffen PR, Blumenthal JA, Kuhn C, Hinderliter AL. Night time blood pressure dipping: the role of the sympathetic nervous system. Am J Hypertens 2002; 15:111-118.
28. Cuspidi C, Meani S, Valerio C, Catini E, Fusi V, Sala C, Zanchetti A. Metabolic syndrome score and ambulatory blood pressure in untreated essential hypertension. Blood Press Monit 2005; 10:175-180.
29. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Almong S, et al. Hyperinsulinemia: a link between hypertension, obesity and glucose tolerance. J Clin Invest 1985; 75:809-817.
30. Swislocki ALM, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 1989; 2:419-423.
31. White WB. Relevance of the trough-to-peak ratio to the 24-h blood pressure load. Am J Hypertens 1996; 9:91-96.
32. White WB, Larocca GM. Improving the utility of the nocturnal hypertension definition by using absolute sleep blood pressure rather than the dipping proportion. Am J Cardiol 2003; 92:1439-1441.